Table 1 Clinical outcomes stratified for ICU mortality.
From: 41st International Symposium on Intensive Care and Emergency Medicine
Outcomes | COVID-19 ECMO Survivors (n = 13) | COVID-19 ECMO Non-survivors (n = 11) | p value |
|---|---|---|---|
Length of stay in ICU (days) | 39.00 ± 28.10 | 26.36 ± 18.42 | 0.15 |
Length of stay in hospital (days) | 49.33 ± 27.50 | 26.36 ± 18.42 | 0.01 |
CVVH during ECMO | 1 (7.69%) | 6 (54.55%) | 0.01 |
Length of ECMO (days) | 13.66 ± 10.73 | 16.64 ± 17.17 | 0.93 |
Stroke | 0 (0.00%) | 3 (27.3%) | 0.04 |
Major bleeding | 6 (46.15%) | 11 (100%) | 0.004 |
Heparin-induced thrombocytopenia | 1 (7.70%) | 1 (9.10%) | 0.90 |